KRICILA Injection (Imipenem 500 mg + Cilastatin 500 mg)

KRICILA Injection combines Imipenem 500 mg and Cilastatin 500 mg, a powerful broad-spectrum antibiotic used to treat serious bacterial infections. Imipenem works by inhibiting bacterial cell wall synthesis, while Cilastatin prevents the breakdown of Imipenem in the kidneys, ensuring maximum effectiveness. KRICILA is administered intravenously or intramuscularly under medical supervision.

KRICILA Injection (Imipenem 500 mg + Cilastatin 500 mg)
Benefits / Uses:
  • Respiratory Tract Infections: Effective against pneumonia, bronchitis, and other severe lung infections.
  • Urinary Tract Infections: Treats complicated and severe infections of the bladder and kidneys.
  • Skin and Soft Tissue Infections: Useful in treating cellulitis, abscesses, and post-surgical infections.
  • Intra-abdominal Infections: Treats peritonitis, intra-abdominal abscesses, and other abdominal infections.
  • Sepsis and Severe Bacterial Infections: Suitable for systemic infections requiring hospital care.
  • Broad-Spectrum Activity: Effective against both gram-positive and gram-negative bacteria, including multi-drug resistant strains.
Dosage & Administration:
  • Administered via intravenous or intramuscular injection as prescribed by a healthcare professional.
  • Dosage varies depending on the severity of infection and patient condition.
  • Follow the complete course to ensure infection clearance.
Caution:
  • Use only under medical supervision.
  • Allergic reactions may occur in patients sensitive to beta-lactam antibiotics.
  • Not intended for viral infections.
  • Inform the doctor of kidney issues, seizures, or other underlying conditions before use.
50+

Countries Served

150+

Products Developed

300+

Research Scientists

25

Years of Excellence

Partner With Us for Better Healthcare Solutions

Join us in our mission to improve lives through innovative pharmaceutical products.